Abstract
Microbes produce a wide range of molecules that can modulate eukaryotic immune responses. These include factors that subvert protective mechanisms in order to facilitate pathogen colonization and persistence. Viral, bacterial and parasite-derived molecules have been identified that can inhibit inflammatory responses. However, in addition to the plethora of microbial factors that suppress immune responses, the most potent immune activators are also of microbial origin. These include the bacterial enterotoxins, parasite-derived excretory-secretory products and viral nucleic acids. In fact, there are examples of immune modulators that can exert either stimulatory or suppressive effects depending on the mode of delivery, dose and experimental model. There is presently great interest in the therapeutic exploitation of these factors, for example as a means to stimulate enhanced immune responses to a new generation of subunit vaccines or to inhibit deleterious immune mediated diseases. This short review, describes representative microbial immunomodulators, their modes of action and the potential for therapeutic application.
Keywords: Immunomodulatory Drugs, enterotoxins, immune responses
Current Topics in Medicinal Chemistry
Title: Molecules of Infectious Agents as Immunomodulatory Drugs
Volume: 4 Issue: 5
Author(s): Ed C. Lavelle, Peter McGuirk and Kingston H.G. Mills
Affiliation:
Keywords: Immunomodulatory Drugs, enterotoxins, immune responses
Abstract: Microbes produce a wide range of molecules that can modulate eukaryotic immune responses. These include factors that subvert protective mechanisms in order to facilitate pathogen colonization and persistence. Viral, bacterial and parasite-derived molecules have been identified that can inhibit inflammatory responses. However, in addition to the plethora of microbial factors that suppress immune responses, the most potent immune activators are also of microbial origin. These include the bacterial enterotoxins, parasite-derived excretory-secretory products and viral nucleic acids. In fact, there are examples of immune modulators that can exert either stimulatory or suppressive effects depending on the mode of delivery, dose and experimental model. There is presently great interest in the therapeutic exploitation of these factors, for example as a means to stimulate enhanced immune responses to a new generation of subunit vaccines or to inhibit deleterious immune mediated diseases. This short review, describes representative microbial immunomodulators, their modes of action and the potential for therapeutic application.
Export Options
About this article
Cite this article as:
Lavelle C. Ed, McGuirk Peter and Mills H.G. Kingston, Molecules of Infectious Agents as Immunomodulatory Drugs, Current Topics in Medicinal Chemistry 2004; 4 (5) . https://dx.doi.org/10.2174/1568026043451249
DOI https://dx.doi.org/10.2174/1568026043451249 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Influenza and Stroke Risk: A Key Target Not to be Missed?
Infectious Disorders - Drug Targets STING Activation and its Application in Immuno-Oncology
Current Topics in Medicinal Chemistry Using Functional Neuroimaging to Investigate the Mechanisms of Action of Selective Serotonin Reuptake Inhibitors (SSRIs)
Current Pharmaceutical Design Pathogenesis of Stroke-Like Episodes in MELAS: Analysis of Neurovascular Cellular Mechanisms
Current Neurovascular Research Isolation of Antibodies From Non-Human Primates for Clinical Use
Current Drug Discovery Technologies Neonatal Fever in the Term Infant: Evaluation and Management Strategies
Current Pediatric Reviews Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients
Current Pharmaceutical Design Proteases in Mosquito Borne Diseases: New Avenues in Drug Development
Current Topics in Medicinal Chemistry DNA Vaccines for Prostate Cancer
Current Cancer Therapy Reviews Astrocyte Infection by HIV-1: Mechanisms of Restricted Virus Replication, and Role in the Pathogenesis of HIV-1-Associated Dementia
Current HIV Research Regulatory T Cells and Tolerogenic Dendritic Cells as Critical Immune Modulators in Atherogenesis
Current Pharmaceutical Design Exosomes and the Emerging Field of Exosome-Based Gene Therapy
Current Gene Therapy Jembrana Disease Virus: Host Responses, Viral Dynamics and Disease Control
Current HIV Research Current Perspective of COVID-19 on Neurology: A Mechanistic Insight
Combinatorial Chemistry & High Throughput Screening Anti-NMDA Receptor Encephalitis in a Patient with a History of Autism Spectrum Disorder
Adolescent Psychiatry Artery of Percheron Infarction: A Characteristic Pattern of Ischemia and Variable Clinical Presentation: A Literature Review
Current Medical Imaging Chitinases: Biomarkers for Human Diseases
Protein & Peptide Letters Gut Homing Molecule Regulation of the Pathogenesis and Treatment of Inflammatory Bowel Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Role of Unani Medicines in Cancer Control and Management
Current Drug Therapy Signal Transduction in HIV Protein-Treated Astrocytes
Current Signal Transduction Therapy